CD9 & CD63 Exosome ELASA Kit, Human

Model: P0301 / P0302

Category: Cell Therapy and Regenerative Medicine

Booth No: M1129

Characteristic

CD9 and CD63 Exosome ELASA Kit, Human
A New Benchmark for Exosome Quantitation: An Innovative Solution Breaking Traditional Method Limitations
In the field of protein research and diagnostics, traditional ELISA (Enzyme-Linked Immunosorbent Assay) technology is widely used due to its high sensitivity and specificity. However, when dealing with small molecules, targets with low immunogenicity, or toxic targets, antibody technology is often limited by development difficulties or insufficient specificity. To address these challenges, we introduce the innovative ELASA (Enzyme-Linked Aptamer-Sorbent Assay) technology, ushering in a new generation of detection solutions.
This product utilizes Genicore's exclusive screening platform to develop Genimer™ aptamer probes that specifically detect the key exosome surface markers CD9 and CD63. It can be used for precise quantitation and efficient preliminary screening. Compared to traditional ELISA, we offer a solution with higher sensitivity, better stability, and greater cost-effectiveness, making it the ideal choice for your exosome research.
Features of the Genimer™ ELASA Kit:
1. 100-fold Increased Sensitivity: Capable of detecting as low as <10⁷ exosomes, offering sensitivity significantly higher than commercially available traditional ELISA (<10⁹ exosomes), greatly enhancing detection accuracy.
2. Highly Specific Recognition of CD9 and CD63: Genimer™ aptamers are specifically designed for CD9 and CD63, effectively reducing non-specific background signals and improving data reliability.
3. Minimal Sample Volume Required: Only approximately 5x10⁶ exosomes are needed per experiment for quantitative analysis, making it particularly suitable for precious or difficult-to-obtain samples.
4. Excellent Stability and Reproducibility: Aptamers are based on chemical synthesis, providing exceptional stability resistant to pH and temperature changes. Storage under refrigeration is sufficient, making operation and storage more convenient.
5. Significant Cost-Effectiveness: Stable aptamer production and high batch consistency result in lower manufacturing and experimental costs compared to competitors.
6. Paired with High-Quality Standard: Each kit batch includes exosome standards produced from Mesenchymal Stem Cells (MSCs) under strict quality control. These standards do not use fusion proteins, providing a more realistic representation of actual samples.
The Genimer™ ELASA Kit can be widely applied in exosome-related research, tumor biomarker analysis, liquid biopsy, regenerative medicine, drug development, and other fields. Whether you seek sensitive detection or stable operation, this kit meets your expectations for a high-quality exosome analysis tool.
Choosing Genimer™ ELASA is a crucial step towards next-generation exosome quantitative analysis.
Welcome to visit our booth to learn more about Genimer™ technology applications and experience the excellent performance of our product firsthand!

Other Products

Products you may be interested in

Highest Rated Products

Back

Menu

CD9 & CD63 Exosome ELASA Kit, Human

Characteristic

Other Products

Products you may be interested in

Highest Rated Products